Company Data
Palisade Bio Inc.
Ticker
PALI
Current Price
$2 -4.76%
Market Cap
$18.2M
Price Target
Refer to Report
Volume
9.0M
52wk Range
$0.53 - $4.318
Overview
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.